The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 22, 2005
Filed:
Jun. 25, 1997
Makoto Yanai, Saitama-ken, JP;
Masashi Suzuki, Saitama-ken, JP;
Norio Oshida, Saitama-ken, JP;
Koji Kawamura, Saitama-ken, JP;
Shigeru Hiramoto, Saitama-ken, JP;
Orie Yasuda, Saitama-ken, JP;
Nobuhiro Kinoshita, Saitama-ken, JP;
Akiko Shingai, Saitama-ken, JP;
Masako Takasu, Saitama-ken, JP;
Makoto Yanai, Saitama-ken, JP;
Masashi Suzuki, Saitama-ken, JP;
Norio Oshida, Saitama-ken, JP;
Koji Kawamura, Saitama-ken, JP;
Shigeru Hiramoto, Saitama-ken, JP;
Orie Yasuda, Saitama-ken, JP;
Nobuhiro Kinoshita, Saitama-ken, JP;
Akiko Shingai, Saitama-ken, JP;
Masako Takasu, Saitama-ken, JP;
Nisshin Seifun Group Inc., Tokyo, JP;
Abstract
Cyclic depsipeptides represented by the formulawherein: R is a straight or branched alkyl group of 5-20 carbon atoms or a straight or branched alkoxymethyl group of 5-15-carbon atoms; A, B, D, E and F independently each other are alanine, valine, leucine, isoleucine, phenylalanine, etc.; W and Z independently each other are aspartic acid, asparagine, glutamic acid or glutamine; and m and n independently each other is 0 or 1, or pharmacologically acceptable salts thereof. The present compounds are prepared according to a method conventionally used in peptide synthesis. The present compounds are useful as an agent for promoting the production of apolipoprotein E, a therapeutic agent for neurologic damages, a therapeutic agent for dementia, an agent for inhibiting the production of apolipoprotein B, an agent for promoting the production of apolipoprotein A1 or a therapeutic agent for hyperlipemia.